According to the latest information from the Hong Kong Stock Exchange, JPMorgan Chase & Co. sold approximately 874,052 shares of SINOPHARM (01099) on June 30.
The transaction was executed at a price of HK$16.0054 per share, resulting in a total consideration of roughly HK$13.99 million.
Following this divestment, JPMorgan's holding in the company now stands at about 80.1123 million shares, representing a stake of 5.97%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments